Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Christopher Leigh Hallemeier

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3598-6709; OpenAlex author ID A5050766065. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
45
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 2 papers · 2022: 3 papers · 2023: none · 2024: 2 papers

Papers 11

  1. Determining the Minimal Clinically Important Difference of the Functional Assessment of Cancer Therapy Hepatobiliary Questionnaire to Evaluate the Change in th… Co-author DOI 10.1016/j.ijrobp.2023.08.009↗
  2. Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma: Systematic Revie… Co-author DOI 10.1097/coc.0000000000001076↗
  3. Patterns of Recurrence After Primary Local Therapy for Pancreatic Ductal Adenocarcinoma - A Critical Review of Rationale and Target Delineation for (Neo)Adjuva… Last author DOI 10.1016/j.prro.2022.06.004↗
  4. Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer. Co-author DOI 10.1245/s10434-021-10991-2↗
  5. FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma. Co-author DOI 10.6004/jnccn.2022.7041↗
  6. Liver Metastasis-Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients: Data From a Multi-institu… Co-author DOI 10.1097/mpa.0000000000001822↗
  7. Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000003284↗
  8. Carbon Ion Radiotherapy in the Treatment of Pancreatic Cancer: A Review. Co-author DOI 10.1097/mpa.0000000000001566↗
  9. Time to Reconsider Staging Laparoscopy in Pancreatic Cancer? First author DOI 10.1200/jco.20.00996↗
  10. Predictors of Locoregional Failure and Impact on Overall Survival in Patients With Resected Exocrine Pancreatic Cancer. Last author DOI 10.1016/j.ijrobp.2015.11.003↗
  11. Preoperative CA 19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent… Co-author DOI 10.1097/coc.0b013e3181f946fc↗

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael G. Haddock · 6 shared papers, 2011–2024 · strength 0.65
  2. Krishan R. Jethwa · 3 shared papers, 2020–2024 · strength 0.57
  3. Mark Joseph Truty · 4 shared papers, 2021–2022 · strength 0.56
  4. Michael L. Kendrick · 4 shared papers, 2016–2022 · strength 0.42
  5. Kenneth Wing Merrell · 3 shared papers, 2016–2024 · strength 0.38
  6. Salma K. Jabbour · 2 shared papers, 2022–2024 · strength 0.38
  7. Thorvardur Ragnar Halfdanarson · 3 shared papers, 2021–2022 · strength 0.36
  8. Sean Patrick Cleary · 3 shared papers, 2021–2022 · strength 0.36
  9. Rondell Patrell Graham · 3 shared papers, 2021–2022 · strength 0.36
  10. Robert R. McWilliams · 3 shared papers, 2021–2022 · strength 0.36
  11. Amro M. Abdelrahman · 2 shared papers, 2022 · strength 0.24
  12. Jennifer A. Yonkus · 2 shared papers, 2022 · strength 0.24
  13. Travis Edward Grotz · 2 shared papers, 2022 · strength 0.24
  14. Roberto Alva‐Ruiz · 2 shared papers, 2022 · strength 0.24
  15. Wen Wee Ma · 2 shared papers, 2022 · strength 0.24
  16. Amit Mahipal · 2 shared papers, 2021–2022 · strength 0.24
  17. Ajit Harishkumar Goenka · 2 shared papers, 2021–2022 · strength 0.23
  18. Shane S. Neibart · 1 shared paper, 2022 · strength 0.20
  19. Isabella Zaniletti · 1 shared paper, 2024 · strength 0.20
  20. Todd A. DeWees · 1 shared paper, 2024 · strength 0.20
  21. Gabrielle W. Peters · 1 shared paper, 2020 · strength 0.19
  22. Suzanne M. Russo · 1 shared paper, 2024 · strength 0.18
  23. Leila T. Tchelebi · 1 shared paper, 2024 · strength 0.18
  24. Rachit Kumar · 1 shared paper, 2024 · strength 0.18
  25. William C. Small · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.